Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 294
Selected: 0
NCT IDTitle
NCT04055844Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS
NCT00005984Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia
NCT00617188Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer
NCT00625729Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia
NCT05114837Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALL
NCT04882423Vegetable Intake Effect on Heterocyclic Amine Metabolism
NCT01601548Cancer and Mindfulness-Based Cancer Recovery After Chemotherapy
NCT00287911Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer
NCT06213298Effect of Kava on Anxiety and Stress in Cancer Survivors
NCT00455312Stem Cell Transplant (SCT) for Dyskeratosis Congenita or SAA
NCT01215981Influenza Vaccine Post Allogeneic Transplant
NCT05665543Increasing HPV Vaccination in Pediatric, Adolescent, and Young Adult (PAYA) Cancer Survivors
NCT00703638Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors
NCT02666105Exemestane in Post-Menopausal Women With NSCLC
NCT01158456Metabolism of NNK Among African Americans
NCT00005993Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer
NCT00602693T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer
NCT00855114Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery
NCT02410239MT2014-14 IT-MSC for Advanced Cerebral Adrenoleukodystrophy (cALD)
NCT00609739Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation
NCT06544811American Indian Smokefree Native RCT
NCT03314974Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
NCT03383055CMV-MVA Triplex Vac.Enhance Adap. NK Cell Recon. After Auto HSCT in pt Lymphoid Malig
NCT01652092Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
NCT00612716Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
NCT00176852Stem Cell Transplant for Hemoglobinopathy
NCT00392782Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease
NCT00176917Stem Cell Transplantation for Hurler
NCT03125642Auto Stem Cell Transplant for Lymphoma Patients
NCT01581970Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer
NCT01626092Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders
NCT00356941Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLC
NCT04426669A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
NCT02991898Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies
NCT02722668UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
NCT02162420Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia
NCT02227797MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients
NCT01012362Study of Pazopanib and Ixabepilone in Patients With Solid Tumors
NCT01850888MIBG for Refractory Neuroblastoma and Pheochromocytoma
NCT03152526CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR
NCT01312818Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)
NCT01885897IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT
NCT03946423BAriaTric Surgery After Breast Cancer Treatment (BATS)
NCT00381888Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
NCT03365661QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML
NCT00903630Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
NCT00373152MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer
NCT00818649Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
NCT00167206Stem Cell Transplantation for Fanconi Anemia
NCT02605421Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma